Evidence map›Paper›PMID 38505671›Full record

ArticleBioImpacts : BI2024

Comparative molecular docking and toxicity between carbon-capped metal oxide nanoparticles and standard drugs in cancer and bacterial infections.

Navid Mohammadjani, Sahand Karimi, Musa Moetasam Zorab, Morahem Ashengroph, Mehran Alavi

Open access · diamondAbstract read
In one paragraph

Article in BioImpacts : BI, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 11 citations in OpenAlex.

  1. RSC advances · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Navid MohammadjaniDepartment of Biological Science, Faculty of Science, University of Kurdistan, Sanandaj, Kurdistan, Iran.ORCID https://orcid.org/0000-0003-3713-4451
Sahand KarimiDepartment of Biological Science, Faculty of Science, University of Kurdistan, Sanandaj, Kurdistan, Iran.
Musa Moetasam ZorabDepartment of Physics, University of Halabja, Kurdistan Region, Iraq.ORCID https://orcid.org/0000-0001-6792-0010
Morahem AshengrophDepartment of Biological Science, Faculty of Science, University of Kurdistan, Sanandaj, Kurdistan, Iran.ORCID https://orcid.org/0000-0001-6821-0192
Mehran AlaviDepartment of Biological Science, Faculty of Science, University of Kurdistan, Sanandaj, Kurdistan, Iran.ORCID https://orcid.org/0000-0002-5691-8326
University of Kurdistan · IRRazi University · IRUniversity of Halabja · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Nanoparticles (NPs) are of great interest in the design of various drugs due to their high surface-to-volume ratio, which result from their unique physicochemical properties. Because of the importance of examining the interactions between newly designed particles with different targets in the case of various diseases, techniques for examining the interactions between these particles with different targets, many of which are proteins, are now very common. Methods: In this study, the interactions between metal oxide nanoparticles (MONPs) covered with a carbon layer (Ag Results: According to the data obtained from the semi flexible molecular docking process, MgO and Fe Conclusion: The toxicity of MONPs is one of the major challenges in the development of drugs based on them. According to the results of these molecular docking studies, MgO and Fe

Indexed as

Bacterial infectionComputer-aided drug designMetal oxide nanoparticleMolecular dockingVirtual screening

Identifiers

PMID38505671
PMCPMC10945298
OpenAlexW4387462923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.